Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: Results of two randomized studies

International Journal of Dermatology

Volumn 48, Issue 11, 2009, Pages 1236-1245

  Foley, Peter ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Freeman, Michael ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Menter, Alan ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Siller, Gregory ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   El Azhary, Rokea A ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Gebauer, Kurt ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Lowe, Nicholas J ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Jarratt, Michael T ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Murrell, Dedee F ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Rich, Phoebe ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Pariser, David M ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Oseroff, Allan R ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Barnetson, Ross ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Anderson, Christopher ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Kossard, Steven ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Gibson, Lawrence E ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Tope, Whitney D ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Suite 5 ACH House ^*  (Australia)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

^d Fremantle Dermatology   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^g LIVERPOOL HOSPITAL   (Australia)

^h SKIN AND CANCER FOUNDATION AUSTRALIA   (Australia)

ⁱ INSERM U899   (United States)

^j MAYO CLINIC   (United States)

^k Clinical Research Specialists   (United States)

^l DermResearch Inc   (United States)

^m Northwest Cutaneous Research Specialists   (United States)

ⁿ EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^o UNIVERSITY AT BUFFALO   (United States)

^p Advancements in Dermatology   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; PLACEBO;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRUSTING; CYTOREDUCTIVE SURGERY; DEBRIDEMENT; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; ERYTHEMA; EXCISION; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; NODULAR BASAL CELL CARCINOMA; PHASE 3 CLINICAL TRIAL; PHOTODYNAMIC THERAPY; PROSPECTIVE STUDY; PUNCH BIOPSY; RANDOMIZED CONTROLLED TRIAL; SKIN BLEEDING; SKIN BURNING SENSATION; SKIN DISEASE; SKIN PAIN; SKIN STINGING; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; CARCINOMA, BASAL CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROSPECTIVE STUDIES; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 70449433090     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2008.04022.x     Document Type: Article

References (38)

1. Telfer NR, Colver GB, Bowers PW. Guidelines for the management of basal cell carcinoma. Br J Dermatol 1999, 141:415-423.
2. Scrivener Y, Grosshans E, Cribier B. Variations of basal cell carcinomas according to gender, age, location and histopathological type. Br J Dermatol 2002, 147:41-47.
3. McCormack CJ, Kelly JW, Dorevitch AP. Differences in age and body site distribution of the histological subtypes of basal cell carcinoma. A possible indicator of differing causes. Arch Dermatol 1997, 133:593-596.
4. Tope WD, Shaffer JJ, Bolognia JL, Jorizzo JL, Rapini RP. Photodynamic therapy. Dermatology 2003, 2127-2143. In, eds, London, Harcourt Publishers Ltd
5. Varma S, Wilson H, Kurwa HA. Bowen's disease, solar keratoses and superficial basal cell carcinomas treated by photodynamic therapy using a large field incoherent light source. Br J Dermatol 2001, 144:567-574.
6. Wolf P, Rieger E, Kerl H. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. J Am Acad Dermatol 1993, 28:17-21.
7. Wennberg AM, Lindholm LE, Alpsten M. Treatment of superficial basal cell carcinomas using topically applied delta-aminolevulinic acid and a filtered xenon lamp. Arch Dermatol Res 1996, 288:561-564.
8. Peng Q, Warloe T, Berg K. 5-ALA based photodynamic therapy. Clinical research and future challenges. Cancer 1997, 79:2282-2308.
9. Wang I, Bauer B, Andersson-Engels S. Photodynamic therapy utilising topical delta-aminolevulinic acid in non-melanoma skin malignancies of the eyelid and the periocular skin. Acta Ophthalmol Scand 1999, 77:182-188.
10. Morton CA, MacKie RM, Whitehurst C. Photodynamic therapy for basal cell carcinoma: effect of tumor thickness and duration of photosensitizer application on response. Arch Dermatol 1998, 134:248-249.
11. Martin A, Tope WD, Grevelink JM. Lack of selectivity of protoporphyrin IX fluorescence for basal cell carcinoma after topical application of delta-aminolevulinic acid: implications for photodynamic treatment. Arch Dermatol Res 1995, 287:665-674.
12. Morton CA, Brown SB, Collins S. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol 2002, 146:552-567.
13. Braathen LR, Szeimies R-M, Basset-Seguin N. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol 2007, 56:125-143.
14. Peng Q, Soler A, Warloe T. Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate. J Photochem Photobiol B: Biol 2001, 62:140-145.
15. Soler AM, Warloe T, Berner A. A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl-5-aminolevulinate-based photodynamic therapy alone and with prior curettage. Br J Dermatol 2001, 145:467-471.
16. Fritsch C, Homey B, Stahl W. Preferential relative porphyrin enrichment in solar keratoses upon topical application of delta-aminolevulinic acid methylester. Photochem Photobiol 1998, 68:218-221.
17. Angell-Petersen E, Sorensen R, Warloe T. Porphyrin formation in actinic keratosis and basal cell carcinoma after topical application of methyl 5-aminolevulinate. J Invest Dermatol 2005, 22:122005. (Online)
18. Rhodes LE, de Rie M, Enström Y. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma. Results of a multicenter randomized prospective trial. Arch Dermatol 2004, 140:17-23.
19. Horn M, Wolf O, Wulf HC. Topical methyl aminolevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. Br J Dermatol 2003, 149:1242-1249.
20. Basset-Seguin N, Ibbotson S, Emtestam L. Photodynamic therapy using Metvix is as efficacious as cryotherapy in BCC, with better cosmetic results. J Eur Acad Dermatol Venereol 2001, 15:226. [abstract]
21. Vinciullo C, Elliott D, Gebauer K. Photodynamic therapy with topical methyl aminolevulinate for " difficult-to-treat" basal cell carcinoma. Br J Dermatol 2005, 152:765-772.
22. Fleiss JL. Statistical Methods for Rates and Proportions 1981, New York, Wiley & Sons
23. Kuijpers DI, Thissen MR, Thissen CA. Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma. J Drugs Dermatol 2006, 5:642-645.
24. Freeman M, Vinciullo C, Francis D. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix®) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. J Dermatol Treat 2003, 14:99-106.
25. Barlow JO, Zalla MJ, Kyle A. Treatment of basal cell carcinoma with curettage alone. J Am Acad Dermatol 2006, 54:1039-1045.
26. Spencer JM, Tannenbaum A, Sloan L. Does inflammation contribute to the eradication of basal cell carcinoma following curettage and electrodesiccation?. Dermatol Surg 1997, 23:625-630.
27. Grapengiesser S, Ericson M, Gudmundsson F. Pain caused by photodynamic therapy of skin cancer. Clin Exp Dermatol 2002, 27:493-497.
28. Pariser DM, Lowe NJ, Stewart DM. Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. J Am Acad Dermatol 2003, 48:227-232.
29. Morton CA. Photodynamic therapy for nonmelanoma skin cancer and more?. Arch Dermatol 2004, 140:116-120.
30. Lindeburg KEK, Brogaard HMV, Jemec GBE. Pain and photodynamic therapy. Dermatology 2007, 215:206-208.
31. Wiegell SR, Skiveren J, Philipsen PA. Pain during photodynamic therapy is associated with protoporphyrin IX fluorescence and fluence rate. Br J Dermatol 2008, 158:727-733.
32. Weston A, Fitzgerald P. Discrete choice experiment to derive willingness to pay for methyl aminolevulinate photodynamic therapy versus simple excision surgery in basal cell carcinoma. Pharmacoeconomics 2004, 22:1195-1208.
33. Ceilly RI, Del Rosso JQ. Current modalities and new advances in the treatment of basal cell carcinoma. Int J Dermatol 2006, 45:489-498.
34. Silverman MK, Kopf AW, Gladstein AH. Recurrence rates of treated basal cell carcinomas. Part 4: X-ray therapy. J Dermatol Surg Oncol 1992, 18:549-554.
35. Martin H, Strong E, Spiro RH. Radiation-induced skin cancer of the head and neck. Cancer 1970, 25:61-71.
36. Kasche A, Luderschmidt S, Ring J. Photodynamic therapy induces less pain in patients with methyl aminolevulinate compared to aminolevulinic acid. J Drugs Dermatol 2006, 5:353-356.
37. Borelli C, Herzinger T, Merk K. Effect of subcutaneous infiltration anesthesia on pain in photodynamic therapy: a controlled open pilot trial. Dermatol Surg 2007, 33:314-318.
38. Morton CA. Treating basal cell carcinoma: has photodynamic therapy come of age? (Editorial). Br J Dermatol 2001, 145:1-2.